hair loss with glp 1 drugs GLP-1 Medications & Loss: How Hair Extensions Can Help Understanding Hair Thinning Linked to

The list of FDA-approved indications for this class of medication has grown as of late (and currently includes type 2 diabetes, obesity, cardiovascular event risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease), and areas of interest for potential future indications are just as long and farreaching

Chris Serres: And Obviously, you know, theres a huge public interest in this

Alatassi sees her patients once a month when they start on these drugs and then once every three months

With less muscle tissue, blood glucose levels may rise

The SURMOUNT-OSA results The SURMOUNT-OSA trial enrolled adults with moderate-to-severe obstructive sleep apnea and a body mass index of 30 or higher